Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study.

<h4>Background</h4>Polypharmacy has become a global public health concern particularly in the elderly population. The elderly population is the most susceptible to the negative effects of polypharmacy due to their altered pharmacokinetics and decreased drug clearance. Therefore, polyphar...

Full description

Bibliographic Details
Main Authors: Ayman Al-Dahshan, Noora Al-Kubiasi, Manal Al-Zaidan, Wael Saeed, Vahe Kehyayan, Iheb Bougmiza
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0234386
_version_ 1818575650672345088
author Ayman Al-Dahshan
Noora Al-Kubiasi
Manal Al-Zaidan
Wael Saeed
Vahe Kehyayan
Iheb Bougmiza
author_facet Ayman Al-Dahshan
Noora Al-Kubiasi
Manal Al-Zaidan
Wael Saeed
Vahe Kehyayan
Iheb Bougmiza
author_sort Ayman Al-Dahshan
collection DOAJ
description <h4>Background</h4>Polypharmacy has become a global public health concern particularly in the elderly population. The elderly population is the most susceptible to the negative effects of polypharmacy due to their altered pharmacokinetics and decreased drug clearance. Therefore, polypharmacy can lead to poor health status and higher rates of morbidity and mortality.<h4>Objective</h4>The objective of this study was to determine the prevalence of polypharmacy (≥ 5 drugs) and its association with non-communicable diseases (NCDs) in elderly (≥65 years) Qatari patients attending Primary Healthcare (PHC) centers in Qatar.<h4>Methods</h4>A retrospective cross-sectional analysis was conducted using the Electronic Medical Record (EMR) database of all PHC centers in Qatar for six months (April-September 2017).<h4>Results</h4>Out of 5639 patients screened, 75.5% (95% CI: 74.3-76.6) were exposed to polypharmacy. Females were 1.18 times more likely to have polypharmacy compared to males (95% CI: 1.03-1.34). The multivariate analysis identified having hypertension (AOR 1.71; 95% CI: 1.38-2.13), diabetes (AOR 2.38; 95% CI: 1.97-2.87), dyslipidemia (AOR 1.29; 95% CI: 1.06-1.56), cardiovascular disease (AOR 1.56; 95% CI: 1.25-1.95) and asthma (AOR 1.39; 95% CI: 1.13-1.72) to be independent parameters associated with polypharmacy. Also, the Body Mass Index (BMI) and number of NCDs were found to be significant independent parameters associated with polypharmacy.<h4>Conclusions</h4>The prevalence of polypharmacy among Qatari elderly attending PHC Centers is very high. Our findings confirm the strong relationship between polypharmacy and BMI, and certain NCDs. Healthcare professionals should be educated about the magnitude of polypharmacy, its negative effects, and its associated factors. Best practice guidelines should be developed for improved medical practice in the prescription of medications for such a vulnerable population.
first_indexed 2024-12-15T00:43:47Z
format Article
id doaj.art-c4a7da697be142ec83471c1ed6a7c7fc
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-15T00:43:47Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c4a7da697be142ec83471c1ed6a7c7fc2022-12-21T22:41:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01156e023438610.1371/journal.pone.0234386Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study.Ayman Al-DahshanNoora Al-KubiasiManal Al-ZaidanWael SaeedVahe KehyayanIheb Bougmiza<h4>Background</h4>Polypharmacy has become a global public health concern particularly in the elderly population. The elderly population is the most susceptible to the negative effects of polypharmacy due to their altered pharmacokinetics and decreased drug clearance. Therefore, polypharmacy can lead to poor health status and higher rates of morbidity and mortality.<h4>Objective</h4>The objective of this study was to determine the prevalence of polypharmacy (≥ 5 drugs) and its association with non-communicable diseases (NCDs) in elderly (≥65 years) Qatari patients attending Primary Healthcare (PHC) centers in Qatar.<h4>Methods</h4>A retrospective cross-sectional analysis was conducted using the Electronic Medical Record (EMR) database of all PHC centers in Qatar for six months (April-September 2017).<h4>Results</h4>Out of 5639 patients screened, 75.5% (95% CI: 74.3-76.6) were exposed to polypharmacy. Females were 1.18 times more likely to have polypharmacy compared to males (95% CI: 1.03-1.34). The multivariate analysis identified having hypertension (AOR 1.71; 95% CI: 1.38-2.13), diabetes (AOR 2.38; 95% CI: 1.97-2.87), dyslipidemia (AOR 1.29; 95% CI: 1.06-1.56), cardiovascular disease (AOR 1.56; 95% CI: 1.25-1.95) and asthma (AOR 1.39; 95% CI: 1.13-1.72) to be independent parameters associated with polypharmacy. Also, the Body Mass Index (BMI) and number of NCDs were found to be significant independent parameters associated with polypharmacy.<h4>Conclusions</h4>The prevalence of polypharmacy among Qatari elderly attending PHC Centers is very high. Our findings confirm the strong relationship between polypharmacy and BMI, and certain NCDs. Healthcare professionals should be educated about the magnitude of polypharmacy, its negative effects, and its associated factors. Best practice guidelines should be developed for improved medical practice in the prescription of medications for such a vulnerable population.https://doi.org/10.1371/journal.pone.0234386
spellingShingle Ayman Al-Dahshan
Noora Al-Kubiasi
Manal Al-Zaidan
Wael Saeed
Vahe Kehyayan
Iheb Bougmiza
Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study.
PLoS ONE
title Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study.
title_full Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study.
title_fullStr Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study.
title_full_unstemmed Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study.
title_short Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study.
title_sort prevalence of polypharmacy and the association with non communicable diseases in qatari elderly patients attending primary healthcare centers a cross sectional study
url https://doi.org/10.1371/journal.pone.0234386
work_keys_str_mv AT aymanaldahshan prevalenceofpolypharmacyandtheassociationwithnoncommunicablediseasesinqatarielderlypatientsattendingprimaryhealthcarecentersacrosssectionalstudy
AT nooraalkubiasi prevalenceofpolypharmacyandtheassociationwithnoncommunicablediseasesinqatarielderlypatientsattendingprimaryhealthcarecentersacrosssectionalstudy
AT manalalzaidan prevalenceofpolypharmacyandtheassociationwithnoncommunicablediseasesinqatarielderlypatientsattendingprimaryhealthcarecentersacrosssectionalstudy
AT waelsaeed prevalenceofpolypharmacyandtheassociationwithnoncommunicablediseasesinqatarielderlypatientsattendingprimaryhealthcarecentersacrosssectionalstudy
AT vahekehyayan prevalenceofpolypharmacyandtheassociationwithnoncommunicablediseasesinqatarielderlypatientsattendingprimaryhealthcarecentersacrosssectionalstudy
AT ihebbougmiza prevalenceofpolypharmacyandtheassociationwithnoncommunicablediseasesinqatarielderlypatientsattendingprimaryhealthcarecentersacrosssectionalstudy